- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular approaches to personalizing management of ovarian cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 22, Issue Suppl 8, Pages viii5-viii15
Publisher
Oxford University Press (OUP)
Online
2011-12-16
DOI
10.1093/annonc/mdr516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
- (2011) Nicole D. Fleming et al. GYNECOLOGIC ONCOLOGY
- The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
- (2011) Erin R. King et al. GYNECOLOGIC ONCOLOGY
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long-term outcomes in the second-line treatment of chronic myeloid leukemia
- (2010) Elias Jabbour et al. CANCER
- CA 125 and the detection of recurrent ovarian cancer
- (2010) Robert C. Bast CANCER
- SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
- (2010) Ahmed Ashour Ahmed et al. CANCER CELL
- Tumor Antigen Acrosin Binding Protein Normalizes Mitotic Spindle Function to Promote Cancer Cell Proliferation
- (2010) A. W. Whitehurst et al. CANCER RESEARCH
- Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease
- (2010) Rena Callahan et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Personalized medicine for non-small-cell lung cancer
- (2010) Tony S Mok et al. Expert Review of Anticancer Therapy
- Targeted trials in ovarian cancer
- (2010) Jonathan A. Ledermann et al. GYNECOLOGIC ONCOLOGY
- Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review
- (2010) Munira Essat et al. INTERNATIONAL JOURNAL OF CANCER
- Personalizing Therapy for Ovarian Cancer:BRCAness and Beyond
- (2010) Robert C. Bast et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started